203 related articles for article (PubMed ID: 31142733)
1. Elevated VMP1 expression in acute myeloid leukemia amplifies autophagy and is protective against venetoclax-induced apoptosis.
Folkerts H; Wierenga AT; van den Heuvel FA; Woldhuis RR; Kluit DS; Jaques J; Schuringa JJ; Vellenga E
Cell Death Dis; 2019 May; 10(6):421. PubMed ID: 31142733
[TBL] [Abstract][Full Text] [Related]
2. Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex Vivo.
Liu F; Knight T; Su Y; Edwards H; Wang G; Wang Y; Taub JW; Lin H; Sun L; Ge Y
Target Oncol; 2019 Jun; 14(3):351-364. PubMed ID: 31115744
[TBL] [Abstract][Full Text] [Related]
3. Abivertinib synergistically strengthens the anti-leukemia activity of venetoclax in acute myeloid leukemia in a BTK-dependent manner.
Huang S; Li C; Zhang X; Pan J; Li F; Lv Y; Huang J; Ling Q; Ye W; Mao S; Huang X; Jin J
Mol Oncol; 2020 Oct; 14(10):2560-2573. PubMed ID: 32519423
[TBL] [Abstract][Full Text] [Related]
4. Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment.
Chen X; Glytsou C; Zhou H; Narang S; Reyna DE; Lopez A; Sakellaropoulos T; Gong Y; Kloetgen A; Yap YS; Wang E; Gavathiotis E; Tsirigos A; Tibes R; Aifantis I
Cancer Discov; 2019 Jul; 9(7):890-909. PubMed ID: 31048321
[TBL] [Abstract][Full Text] [Related]
5. Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells.
Rahmani M; Nkwocha J; Hawkins E; Pei X; Parker RE; Kmieciak M; Leverson JD; Sampath D; Ferreira-Gonzalez A; Grant S
Cancer Res; 2018 Jun; 78(11):3075-3086. PubMed ID: 29559471
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia.
Folkerts H; Hilgendorf S; Wierenga ATJ; Jaques J; Mulder AB; Coffer PJ; Schuringa JJ; Vellenga E
Cell Death Dis; 2017 Jul; 8(7):e2927. PubMed ID: 28703806
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of BNIP3L or SQSTM1 alters cellular response to mitochondria target drugs.
Rodrigo R; Mendis N; Ibrahim M; Ma C; Kreinin E; Roma A; Berg S; Blay J; Spagnuolo PA
Autophagy; 2019 May; 15(5):900-907. PubMed ID: 30563411
[TBL] [Abstract][Full Text] [Related]
8. The pancreatitis-induced vacuole membrane protein 1 triggers autophagy in mammalian cells.
Ropolo A; Grasso D; Pardo R; Sacchetti ML; Archange C; Lo Re A; Seux M; Nowak J; Gonzalez CD; Iovanna JL; Vaccaro MI
J Biol Chem; 2007 Dec; 282(51):37124-33. PubMed ID: 17940279
[TBL] [Abstract][Full Text] [Related]
9. Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis.
Rizo A; Olthof S; Han L; Vellenga E; de Haan G; Schuringa JJ
Blood; 2009 Aug; 114(8):1498-505. PubMed ID: 19556423
[TBL] [Abstract][Full Text] [Related]
10. The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells.
Nechiporuk T; Kurtz SE; Nikolova O; Liu T; Jones CL; D'Alessandro A; Culp-Hill R; d'Almeida A; Joshi SK; Rosenberg M; Tognon CE; Danilov AV; Druker BJ; Chang BH; McWeeney SK; Tyner JW
Cancer Discov; 2019 Jul; 9(7):910-925. PubMed ID: 31048320
[TBL] [Abstract][Full Text] [Related]
11. Metformin as an Enhancer for the Treatment of Chemoresistant CD34+ Acute Myeloid Leukemia Cells.
Krastinaite I; Charkavliuk S; Navakauskiene R; Borutinskaite VV
Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790277
[TBL] [Abstract][Full Text] [Related]
12. Targeting GLI1 Suppresses Cell Growth and Enhances Chemosensitivity in CD34+ Enriched Acute Myeloid Leukemia Progenitor Cells.
Long B; Wang LX; Zheng FM; Lai SP; Xu DR; Hu Y; Lin DJ; Zhang XZ; Dong L; Long ZJ; Tong XZ; Liu Q
Cell Physiol Biochem; 2016; 38(4):1288-302. PubMed ID: 27008269
[TBL] [Abstract][Full Text] [Related]
13. An acylhydroquinone derivative produces OXPHOS uncoupling and sensitization to BH3 mimetic ABT-199 (Venetoclax) in human promyelocytic leukemia cells.
Donoso-Bustamante V; Borrego EA; Schiaffino-Bustamante Y; Gutiérrez DA; Millas-Vargas JP; Fuentes-Retamal S; Correa P; Carrillo I; Aguilera RJ; Miranda D; Chávez-Báez I; Pulgar R; Urra FA; Varela-Ramírez A; Araya-Maturana R
Bioorg Chem; 2020 Jul; 100():103935. PubMed ID: 32454391
[TBL] [Abstract][Full Text] [Related]
14. Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.
Jacque N; Ronchetti AM; Larrue C; Meunier G; Birsen R; Willems L; Saland E; Decroocq J; Maciel TT; Lambert M; Poulain L; Hospital MA; Sujobert P; Joseph L; Chapuis N; Lacombe C; Moura IC; Demo S; Sarry JE; Recher C; Mayeux P; Tamburini J; Bouscary D
Blood; 2015 Sep; 126(11):1346-56. PubMed ID: 26186940
[TBL] [Abstract][Full Text] [Related]
15. Autophagy Proteins ATG5 and ATG7 Are Essential for the Maintenance of Human CD34(+) Hematopoietic Stem-Progenitor Cells.
Gomez-Puerto MC; Folkerts H; Wierenga AT; Schepers K; Schuringa JJ; Coffer PJ; Vellenga E
Stem Cells; 2016 Jun; 34(6):1651-63. PubMed ID: 26930546
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia.
Ma J; Zhao S; Qiao X; Knight T; Edwards H; Polin L; Kushner J; Dzinic SH; White K; Wang G; Zhao L; Lin H; Wang Y; Taub JW; Ge Y
Clin Cancer Res; 2019 Nov; 25(22):6815-6826. PubMed ID: 31320594
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response.
Sharon D; Cathelin S; Mirali S; Di Trani JM; Yanofsky DJ; Keon KA; Rubinstein JL; Schimmer AD; Ketela T; Chan SM
Sci Transl Med; 2019 Oct; 11(516):. PubMed ID: 31666400
[TBL] [Abstract][Full Text] [Related]
18. AMPK-PERK axis represses oxidative metabolism and enhances apoptotic priming of mitochondria in acute myeloid leukemia.
Grenier A; Poulain L; Mondesir J; Jacquel A; Bosc C; Stuani L; Mouche S; Larrue C; Sahal A; Birsen R; Ghesquier V; Decroocq J; Mazed F; Lambert M; Andrianteranagna M; Viollet B; Auberger P; Lane AA; Sujobert P; Bouscary D; Sarry JE; Tamburini J
Cell Rep; 2022 Jan; 38(1):110197. PubMed ID: 34986346
[TBL] [Abstract][Full Text] [Related]
19. VMP1 related autophagy and apoptosis in colorectal cancer cells: VMP1 regulates cell death.
Qian Q; Zhou H; Chen Y; Shen C; He S; Zhao H; Wang L; Wan D; Gu W
Biochem Biophys Res Commun; 2014 Jan; 443(3):1041-7. PubMed ID: 24365149
[TBL] [Abstract][Full Text] [Related]
20. Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models.
Lehmann C; Friess T; Birzele F; Kiialainen A; Dangl M
J Hematol Oncol; 2016 Jun; 9(1):50. PubMed ID: 27353420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
